Advanced Pharmacovigilance
Course
In The Rembrandt Hotel, London
Description
-
Type
Practical seminar
-
Level
Advanced
-
Location
The rembrandt hotel, london
-
Class hours
8h
-
Duration
3 Days
This course is designed for those with at least two years worth of knowledge in drug safety and will provide a comprehensive, yet practical assessment of the main regulations required to produce a compliant reporting company pharmacovigilance Inspection.
KEY TOPICS TO BE COVERED
Training for Drug Safety Reporting Duties, Audits and Expectations Risk Based Inspections
The DDPS retirement and the New PV Master file in the EU
Compliance and Drug Safety
Product Safety Reviews Purpose and Function (incorporating the new EU Signal Analysis Requirements)
Developing Company Core System Information CIOMS III
Safety Reporting in Licensing Agreements
PSURs Timing, Content and the DSUR and the New ICH E2C (2nd Revision requirements)
Implications for Safety Reporting in Global Clinical Trials
Risk/Benefit Determinations
Risk Management Plans
Facilities
Location
Start date
Start date
About this course
Expand your global safety knowledge
Enhance your team’s capabilities and compliance in both the regulations and your company’s expectations
Help ensure you build and maintain a quality Pharmacovigilance department ready for any Pharmacovigilance inspection
Participate in group workshop sessions and discuss how to apply the legislation to ensure compliance, especially to satisfy regulatory inspection
This course would be of maximum benefit to those safety professionals who are working both in the Clinical and Post-Marketing Safety arena including QA for auditing. The course covers very diverse activities within the Safety Department and would be advantageous to those who have either multifunction responsibilities or Medical Directors who manage teams in the various disciplines
At least 2 years worth of knowledge in Drug Safety.
Reviews
Subjects
- Risk
- Compliance
- Risk Management
- Global
- IT risk
- Regulations
- Pharmacovigilance
- Pharma
- Training
- Management
Teachers and trainers (1)
Graeme Ladds
Director, PharSafer
Course programme
This course is designed for those with at least two years worth of knowledge in drug safety and will provide a comprehensive, yet practical assessment of the main regulations required to produce a compliant reporting company pharmacovigilance Inspection.
KEY TOPICS TO BE COVERED
- Training for Drug Safety Reporting Duties, Audits and Expectations Risk Based Inspections
- The DDPS retirement and the New PV Master file in the EU
- Compliance and Drug Safety
- Product Safety Reviews Purpose and Function (incorporating the new EU Signal Analysis Requirements)
- Developing Company Core System Information CIOMS III
- Safety Reporting in Licensing Agreements
- PSURs Timing, Content and the DSUR and the New ICH E2C (2nd Revision requirements)
- Implications for Safety Reporting in Global Clinical Trials
- Risk/Benefit Determinations
- Risk Management Plans
- Expand your global safety knowledge
- Enhance your team’s capabilities and compliance in both the regulations and your company’s expectations
- Help ensure you build and maintain a quality Pharmacovigilance department ready for any Pharmacovigilance inspection
- Participate in group workshop sessions and discuss how to apply the legislation to ensure compliance, especially to satisfy regulatory inspection
Advanced Pharmacovigilance